informational

PowerPort vs. Other Port Catheters — Key Differences

Preparing your case review…
Written By
People's Justice Legal Research Team

Understanding Different Types of Venous Access Devices

Patients requiring long-term intravenous access for chemotherapy, nutrition, or repeated blood draws have several device options. Implantable ports — placed entirely under the skin — offer the advantage of no external tubing and can remain in place for years. Tunneled catheters such as Hickman and Broviac catheters exit through the skin and require daily maintenance. Peripherally inserted central catheters (PICC lines) are placed through arm veins and are intended for shorter-term use (weeks to months). The choice between these devices involves trade-offs in convenience, maintenance burden, infection risk, and longevity.

The Bard PowerPort is specifically a power-injectable port — meaning it is engineered to withstand the high injection pressures of CT contrast administration (up to 5 mL/sec) as well as standard infusion. This power-injection capability was a differentiating marketing feature. The polyurethane catheter tubing was chosen to provide the structural rigidity needed to withstand power injection forces. Competing silicone catheters in standard implantable ports are not power-injectable at standard pressures, though power-injectable silicone port catheters have since been developed and marketed.

Hickman Catheter

Hickman catheters (and the related Broviac catheter) are tunneled, externally-exiting central venous catheters made from silicone tubing. The catheter is tunneled under the chest skin but exits through the skin, with the external portion requiring a sterile dressing and daily heparin flushing by the patient or caregiver. Because there is no implanted port, there is no subcutaneous reservoir and no access needle required. Hickman catheters use silicone tubing throughout — they do not experience the ESC fracture mechanism that affects polyurethane PowerPort catheters. However, their external exposure creates different risks: higher infection rates from the skin exit site and accidental dislodgement.

Silicone Mediport and Other Implantable Ports

Several manufacturers produce implantable ports with silicone catheter tubing — including certain Vortex Port and Titanium Port products from AngioDynamics and others. These silicone-catheter ports provide the same subcutaneous convenience as the PowerPort — no external hardware, accessed only when needed — while using catheter tubing that does not degrade through the ESC mechanism that fractures polyurethane. Plaintiffs in the PowerPort litigation argue that the existence of silicone-catheter implantable ports demonstrates that a safer design alternative was available and feasible when Bard chose to use polyurethane.

PICC Lines

Peripherally inserted central catheters (PICCs) are inserted through a peripheral arm vein (typically the basilic or cephalic vein) and advanced until the tip rests in the superior vena cava. They are intended for short to medium-term use (weeks to several months) and are commonly used in patients who need central venous access but do not warrant a permanent implantable port. PICCs use polyurethane or silicone tubing; polyurethane PICC fractures have been reported but are generally less common than PowerPort fractures due to shorter implant durations. PICCs exit through the arm skin and require maintenance. They do not involve the clavicle-first rib pinch-off mechanism that is a primary driver of PowerPort fracture because the insertion site and catheter routing are different.

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Related Topics

Related Pages

PowerPort Catheter Fracture — How It Happens

Bard PowerPort catheters fracture through a well-documented mechanism called environmental stress cracking (ESC) of polyurethane — a process that was scientifically foreseeable at the time of device design. The fracture is silent and painless, meaning most patients have no idea their catheter has broken until complications force diagnostic imaging.

powerport-fracturepolyurethane-degradationenvironmental-stress-cracking
Learn more

PowerPort MDL Settlement Timeline — What to Expect

MDL mass tort litigation follows a predictable multi-year progression from case filing through bellwether trials to global settlement. Understanding each phase helps PowerPort plaintiffs set realistic expectations for timing and the factors that determine individual settlement amounts.

powerport-settlementmdl-settlementbellwether-trial
Learn more

PowerPort Catheter Migration — Where Fragments Go

When a PowerPort catheter fractures, the free fragment enters the central venous circulation and travels to the heart and lungs following the path of venous blood flow. The fragment's final resting location determines the severity of injury — from retrievable right-heart positions to life-threatening peripheral pulmonary artery lodgment.

catheter-migrationfragment-embolismcardiac-tamponade
Learn more

Bard PowerPort MDL in the District of Arizona

MDL No. 3:22-md-03062 in the U.S. District Court for the District of Arizona is the central federal forum for all Bard PowerPort catheter fracture cases. Understanding how the MDL works, where it currently stands, and what participation means for individual plaintiffs is essential for anyone considering a PowerPort lawsuit.

bard-powerport-mdlmdl-arizonamultidistrict-litigation
Learn more

PowerPort Removal Surgery — How Fractured Catheters Are Retrieved

Retrieval of a fractured PowerPort catheter fragment requires either percutaneous cardiac catheterization or open thoracic surgery, depending on fragment location and accessibility. The retrieval procedure itself carries procedural risks, and failure to retrieve leaves the patient with an ongoing foreign body infection and cardiac risk.

powerport-retrievalcatheter-removalcardiac-catheterization
Learn more

PowerPort Sepsis and Infection Risk

A fractured PowerPort catheter fragment acts as a permanent intravascular nidus for infection — a foreign body that bacteria colonize with a protective biofilm that antibiotics cannot eradicate without removing the fragment. For immunocompromised cancer patients, this infection risk is particularly life-threatening.

powerport-sepsispowerport-infectionendocarditis
Learn more

PowerPort Cardiac Perforation — Heart Surgery Risk

Cardiac perforation by a fractured PowerPort catheter fragment is a life-threatening emergency. The thin-walled right ventricle is particularly vulnerable to penetration by a fragment's sharp edge, causing cardiac tamponade — a surgical emergency that can be fatal within minutes without treatment.

cardiac-perforationcardiac-tamponadepowerport-heart
Learn more

Becton Dickinson Liability — BD's Acquisition of Bard

Becton, Dickinson and Company (BD) acquired C.R. Bard in 2017 for $24 billion and assumed full corporate liability for all Bard product claims, including the PowerPort. BD now faces claims not only for Bard's pre-acquisition conduct but also for BD's own post-acquisition decisions to continue selling the PowerPort without redesigning or adequately warning about the fracture risk.

becton-dickinsonbard-acquisitionbd-powerport
Learn more

PowerPort Evidence and Records — What You Need for Your Case

Building a strong PowerPort catheter lawsuit requires gathering specific categories of medical and device records. Even if you no longer have the physical device, documentary evidence of the fracture, fragment location, and resulting injury is sufficient to support a claim.

powerport-evidencemedical-recordsimplant-card
Learn more
Parent Case

Bard PowerPort Catheter Lawsuit

The Bard PowerPort is an implantable venous access device — a small port placed under the skin, typically in the chest — that allows medical professionals to administer chemotherapy, draw blood, and deliver medications without repeated needle sticks. Millions of patients have received PowerPort devices since C.R. Bard introduced them in the 1990s. The devices are especially common among cancer patients who require long-term intravenous access. Beginning in the early 2010s, patients, physicians, and researchers began documenting a disturbing pattern: the polyurethane catheter tubing attached to the port was fracturing inside the body. Fragments of the catheter — sometimes several centimeters long — were entering the bloodstream and migrating toward the heart and lungs. The resulting complications range from serious to fatal: cardiac perforation, cardiac tamponade, pulmonary embolism, sepsis, and endocarditis. Becton Dickinson (BD) acquired C.R. Bard in 2017 for $24 billion, inheriting both the PowerPort product line and the mounting litigation. In 2022, a federal multidistrict litigation was established in the U.S. District Court for the District of Arizona to consolidate cases nationwide. Legal claims proceed under theories of design defect, manufacturing defect, failure to warn, and negligence. Patients who received a PowerPort catheter and subsequently experienced catheter fracture, fragment migration, infection, cardiac complications, or unexplained symptoms may be entitled to substantial compensation.

View full case overview